Drug: tyvaso (treprostinil) 81.2/ML, NDC #66302-0206-02 - bulk funded for FY2018
Ended Awarded Last action
- Contract number
- VA26018J2278
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $45,384
Award facts
- Contract value 100% obligated
- $45,383.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20910, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$63,816 | |
| Original award | $109,200 |
Quick answers
Who was awarded contract VA26018J2278?
VA26018J2278 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2017.
How much is contract VA26018J2278 worth?
The government has obligated $45,384 on VA26018J2278.
Is contract VA26018J2278 an order under another contract?
Yes. VA26018J2278 is a BPA call under V797D40275-VA797P15A0007, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA26018J2278 competed?
The extent of competition for VA26018J2278 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award